Army Joseph 4
4 · VAPOTHERM INC · Filed Feb 29, 2024
Insider Transaction Report
Form 4
VAPOTHERM INCVAPO
Army Joseph
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2024-02-27+8,921→ 8,921 totalExercise: $0.92Exp: 2029-01-11→ Common Stock (8,921 underlying) - Award
Stock Option (right to buy)
2024-02-27+22,831→ 22,831 totalExercise: $0.92Exp: 2030-01-01→ Common Stock (22,831 underlying) - Award
Stock Option (right to buy)
2024-02-27+7,533→ 7,533 totalExercise: $0.92Exp: 2030-01-01→ Common Stock (7,533 underlying) - Award
Stock Option (right to buy)
2024-02-27+6,925→ 6,925 totalExercise: $0.92Exp: 2031-01-01→ Common Stock (6,925 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−24→ 0 total(indirect: By Spouse)Exercise: $137.20Exp: 2029-01-11→ Common Stock (24 underlying) - Award
Stock Option (right to buy)
2024-02-27+24→ 24 total(indirect: By Spouse)Exercise: $0.92Exp: 2029-01-11→ Common Stock (24 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−8,921→ 0 totalExercise: $137.20Exp: 2029-01-11→ Common Stock (8,921 underlying) - Award
Stock Option (right to buy)
2024-02-27+6→ 6 total(indirect: By Spouse)Exercise: $0.92Exp: 2028-01-17→ Common Stock (6 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−6→ 0 total(indirect: By Spouse)Exercise: $13.44Exp: 2028-01-17→ Common Stock (6 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−22,831→ 0 totalExercise: $97.28Exp: 2030-01-01→ Common Stock (22,831 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−7,533→ 0 totalExercise: $97.28Exp: 2030-01-01→ Common Stock (7,533 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−6,925→ 0 totalExercise: $214.88Exp: 2031-01-01→ Common Stock (6,925 underlying)
Holdings
- 392,096
Common Stock
- 62(indirect: By Spouse)
Common Stock
- 40,625(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]This option, which was previously subject to four-year vesting, is fully vested.
- [F2]The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.
- [F3]This option vested as to 25% of the underlying shares on January 1, 2021, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
- [F4]This option is held by the Reporting Person's spouse who is an employee of the Issuer and received the option in connection with that role and consistent in amount with that role.